 BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 15, 2022 GLOBE NEWSWIRE -- Roivant Sciences Nasdaq: ROIV, a biopharmaceutical company dedicated to improving the delivery of healthcare to patients, today announced that it will host a live conference call and webcast at 8:00 a.m. EDT on Tuesday, June 28, 2022 to report its financial results for the fourth quarter and fiscal year ended March 31, 2022 and provide a corporate update. 